Effect of Olive Pomace Oil on Blood Sugar Levels

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the potential benefits of olive pomace oil in managing blood glucose levels in individuals with type 2 diabetes and those at risk of developing the disease. Participants will consume meals with either olive pomace oil or a comparison oil, and their blood glucose responses will be measured. The study includes both a postprandial phase, where immediate blood sugar responses are assessed, and a chronic phase, where the long-term effects of daily olive pomace oil consumption are evaluated. The goal is to determine if olive pomace oil can improve glucose homeostasis and reduce inflammation in these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Fasting blood glucose between 100-126 mg/dL and/or
* Glycated haemoglobin (HbA1c) between 5.7-6.4% and/or
* Diabetic persons with Fasting blood glucose \>126 mg/dL and/or
* Diabetic persons with Glycated haemoglobin (HbA1c) \> 6.4%

Exclusion Criteria:

* Kidney or liver diseases
* Gastrointestinal diseases (irritable bowel syndrome, Crohn disease, chronic bowel inflammation)
* Food allergies/intolerances
* Vegetarians/vegans
* Smoking
* Pregnant or lactating women
* On prescription drugs other than for hypertension/thyroid/dyslipidemia/glucose control, or changes in dosage in the last 3 months
* Consumption of vitamins, dietary supplements or nutraceuticals

Where it's running

• Institute of Food Science, Technology and Nutrition (ICTAN-CSIC)
  Madrid, Madrid, Spain Recruiting

Study contacts

• Principal investigator: Laura Bravo, Professor — Ictan-Csic
• Study coordinator: Laura Bravo, Professor
• Email: lbravo@ictan.csic.es
• Phone: +34 91 5492300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Omnipod 5 in France: one-year real-world follow-up (Optimal-B)

  This study will see if the Omnipod 5 automated insulin delivery system helps children and adults with type 1 diabetes in France improve glucose control, quality of life, and reduce acute diabetes complications over 12 months.

  Recruiting at 23 sites Insulet Corporation · Angers and 23 other locations · NCT07317102

• Connecting clinics and community partners to address unmet social needs for people with diabetes in rural Kentucky

  This project tries a clinic–community program to help adults with diabetes in two rural Kentucky communities get services for unmet social needs.

  Recruiting University of Kentucky · Lexington, Kentucky · NCT07196007

• Continuous glucose monitoring for adults with type 2 diabetes in underserved communities

  This project will test whether giving continuous glucose monitors to uninsured or Medicaid-insured adults with type 2 diabetes who take daily insulin helps them manage their blood sugar better than standard fingerstick monitoring.

  Recruiting Tulane University · New Orleans, Louisiana · NCT07135531

• iLet Bionic Pancreas started through primary care for adults on insulin

  This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.

  Recruiting University of Colorado, Denver · Aurora, Colorado and 1 other locations · NCT07011147

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

• App to support post-hospital care for people with multiple chronic conditions

  This trial will test a smartphone/tablet app to help people aged 55+ with heart failure, diabetes, or chronic kidney disease manage their care after leaving the hospital.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06051058

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.